1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Metabolic pathways in immune senescence and inflammaging : Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology
(
- Contribution to journal › Article
- 2016
-
Mark
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
(
- Contribution to journal › Scientific review
-
Mark
ARIA 2016 : Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle
(
- Contribution to journal › Scientific review
- 2004
-
Mark
Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma
(
- Contribution to journal › Article
- 2003
-
Mark
Study of inclusive J/psi production in two-photon collisions at LEP II with the DELPHI detector
2003) In Physics Letters. Section B: Nuclear, Elementary Particle and High-Energy Physics 565(1-4). p.76-86(
- Contribution to journal › Article
- 1999
-
Mark
Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society
(
- Contribution to journal › Article